Laboratory Centrifuges Market To Generate $2,541.2 Million Revenue by 2030

The global laboratory centrifuges market was valued at USD 1,949.8 million in 2023, which is expected to reach USD 2,541.2 million by 2030, progressing with a CAGR of 4.0% during 2024–2030. This is attributed to the rise in R&D activity in biotechnology and pharmaceutical companies.

Moreover, the introduction of high-speed centrifuges, which reduce the time required for the process, is propelling the growth of the market, For instance, Auto-Lock Rotor by Thermo Fisher Scientific Inc. enables people to switch rotors effectively and quickly.

Further, in April 2021, Eppendorf SE introduced a new centrifuge to increase efficiency in the laboratory, Centrifuge 5910 Ri. The new centrifuge is the successor to the popular Centrifuge 5910 R. With the introduction of Centrifuge 5910 Ri, Eppendorf SE now offers more features to simplify and boost the centrifugation steps of the workflow.

Equipment Accounted for Larger Share

The equipment category held the larger market share in 2023, and it is expected to grow at a significant CAGR during 2024–2030. This is due to the advancement in centrifugation equipment, such as multipurpose centrifuges, microcentrifuges, ultracentrifuges, and minicentrifuges.

The accessories division also holds a significant share in the market. This is because of the repeated purchase of bottles, buckets, and tubes, many of which can only be used once, to prevent sample contamination. Moreover, they are the key accessory used during the process because of their intrinsic purpose of holding the samples.

Fixed-Angle Rotors Hold Largest Share

Fixed-angle rotors held the largest share of the market in 2023. This is because of the increasing research activities and benefits of fixed-angle rotors, such as fast timing and good resolution.

General-Purpose Category Accounts for Largest Share

The general-purpose centrifuges category generated the highest revenue in 2023. This is because of the increasing number of people requiring a diagnosis of blood-related diseases and the growing extent of cellular research being conducted around the world for understanding genetic diseases.

Diagnostics Category Is Expected To Hold Largest Share

The diagnostics category held the largest share of the market in 2023, due to the rising prevalence of diseases and the surging awareness of their early diagnosis. Moreover, in laboratories, centrifuges are routinely used to extract blood cells from plasma, remove sediments from urine, and ascertain the volume fraction of the erythrocytes in the blood sample.

Hospitals Are Major End Users of Centrifuges

The hospitals category dominated the laboratory centrifuges market in 2023. This is attributed to the increasing prevalence of diseases, advancements in centrifuges for the separation of blood components, rising number of hospitals in developing countries, and surging awareness of the early diagnosis of diseases.

North America Held Largest Share

North America held the largest share, of 35%, in 2023, and it is expected to grow with a significant CAGR during 2024–2030. This is because of the efforts of the market players to expand their business. For instance, in July 2022, W. R. Grace & Co. announced that it was expanding its contract development and manufacturing facility in South Haven. Among other things, the expansion was for HASTELLOY centrifuge for isolation, which enhances the commercial capability of the cGMP-compliant site.

Key market players are Thermo Fisher Scientific Inc., Danaher Corporation, Eppendrof AG, KUBOTA Corporation, Sigma Laborzentrifugen GmbH, Andreas Hettich GmbH & Co. KG, Sartorius AG, HERMLE Labortechnik GmbH, Cardinal Health Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Haier Biomedical.